|
EA003294B1
(ru)
*
|
1995-12-08 |
2003-04-24 |
Агурон Фармасьютикалс, Инк. |
Ингибиторы металлопротеиназы, фармацевтические композиции, их содержащие, и их фармацевтические применения
|
|
US6500948B1
(en)
|
1995-12-08 |
2002-12-31 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof
|
|
FR2748026B1
(fr)
*
|
1996-04-26 |
1998-06-05 |
Adir |
Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
ATE226573T1
(de)
*
|
1996-08-28 |
2002-11-15 |
Procter & Gamble |
Heterozyklische metalloproteaseinhibitoren
|
|
US5977408A
(en)
*
|
1996-10-16 |
1999-11-02 |
American Cyanamid Company |
Preparation and use of β-sulfonamido hydroxamic acids as matrix metalloproteinase and TACE inhibitors
|
|
US6228869B1
(en)
|
1996-10-16 |
2001-05-08 |
American Cyanamid Company |
Ortho-sulfonamido bicyclic hydroxamic acids as matrix metalloproteinase and TACE inhibitors
|
|
US5929097A
(en)
*
|
1996-10-16 |
1999-07-27 |
American Cyanamid Company |
Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
|
|
US5962481A
(en)
|
1996-10-16 |
1999-10-05 |
American Cyanamid Company |
Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
|
|
US6548524B2
(en)
|
1996-10-16 |
2003-04-15 |
American Cyanamid Company |
Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
|
|
CA2268418A1
(en)
*
|
1996-10-22 |
1998-04-30 |
Pharmacia & Upjohn Company |
.alpha.-amino sulfonyl hydroxamic acids as matrix metalloproteinase inhibitors
|
|
US6174915B1
(en)
|
1997-03-25 |
2001-01-16 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
US6008243A
(en)
*
|
1996-10-24 |
1999-12-28 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
|
|
SG88737A1
(en)
|
1996-10-30 |
2002-05-21 |
Tanabe Seiyaku Co |
S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof
|
|
JP3563411B2
(ja)
*
|
1997-01-23 |
2004-09-08 |
エフ・ホフマン−ラ ロシュ アーゲー |
スルファミド−メタロプロテアーゼ阻害剤
|
|
ZA98376B
(en)
*
|
1997-01-23 |
1998-07-23 |
Hoffmann La Roche |
Sulfamide-metalloprotease inhibitors
|
|
US6376506B1
(en)
|
1997-01-23 |
2002-04-23 |
Syntex (U.S.A.) Llc |
Sulfamide-metalloprotease inhibitors
|
|
US5985900A
(en)
*
|
1997-04-01 |
1999-11-16 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
DE19719817A1
(de)
*
|
1997-05-13 |
1998-11-19 |
Hoechst Ag |
Substituierte 6- und 7-Aminotetrahydroisochinolincarbonsäuren
|
|
CA2297988A1
(en)
*
|
1997-08-04 |
1999-02-11 |
Amgen Inc. |
Hydroxamic acid substituted fused heterocyclic metalloproteinase inhibitors
|
|
CN1138760C
(zh)
*
|
1997-10-06 |
2004-02-18 |
惠氏控股公司 |
作为基质金属蛋白酶和tace抑制剂的邻亚磺酰氨基二环杂芳基异羟肟酸的制备和用途
|
|
US6130220A
(en)
*
|
1997-10-16 |
2000-10-10 |
Syntex (Usa) Inc. |
Sulfamide-metalloprotease inhibitors
|
|
FR2771095B1
(fr)
*
|
1997-11-14 |
1999-12-17 |
Adir |
Nouveaux inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US6107291A
(en)
*
|
1997-12-19 |
2000-08-22 |
Amgen Inc. |
Azepine or larger medium ring derivatives and methods of use
|
|
US6335329B1
(en)
|
1997-12-19 |
2002-01-01 |
Amgen Inc. |
Carboxylic acid substituted heterocycles, derivatives thereof and methods of use
|
|
US6071903A
(en)
*
|
1998-01-27 |
2000-06-06 |
American Cyanamid Company |
2,3,4,5-tetrahydro-1H-[1,4]-benzodiazepine-3-hydroxyamic acids
|
|
CN1293663A
(zh)
*
|
1998-01-27 |
2001-05-02 |
美国氰胺公司 |
为基质金属蛋白酶抑制剂的2,3,4,5－四氢－1h－[1,4]苯并二氮杂䓬－3－异羟肟酸
|
|
BR9910678A
(pt)
|
1998-05-14 |
2001-10-02 |
Du Pont Pharm Co |
Composto, composição farmacêutica, método para traramento ou prevenção de uma doença inflamatória, método para tratamento de uma condição ou uma doença mediada por mmps, tnf, agrecanase, ou um composto dos mesmos, em um mamìfero, método de redução de nìveis de tnf em pacientes, sem a inibição de mmps, método para tratamento de uma condição ou uma doença e uso de um novo composto
|
|
AU6228499A
(en)
*
|
1998-10-22 |
2000-05-08 |
Akzo Nobel N.V. |
Tetrahydropyridopyridine derivatives and intermediates for producing the same
|
|
US20040122011A1
(en)
*
|
1998-12-23 |
2004-06-24 |
Pharmacia Corporation |
Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapy
|
|
US6340691B1
(en)
|
1999-01-27 |
2002-01-22 |
American Cyanamid Company |
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors
|
|
US6277885B1
(en)
|
1999-01-27 |
2001-08-21 |
American Cyanamid Company |
Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
US6762178B2
(en)
|
1999-01-27 |
2004-07-13 |
Wyeth Holdings Corporation |
Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
AR022423A1
(es)
*
|
1999-01-27 |
2002-09-04 |
American Cyanamid Co |
Compuestos derivados de acidos 2,3,4,5-tetrahidro-1h-[1,4]benzodiazepina-3-hidroxamicos, composicion farmaceutica que los comprenden, y el uso de losmismos para la manufactura de un medicamento
|
|
US6753337B2
(en)
|
1999-01-27 |
2004-06-22 |
Wyeth Holdings Corporation |
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors
|
|
US6326516B1
(en)
|
1999-01-27 |
2001-12-04 |
American Cyanamid Company |
Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
US6225311B1
(en)
|
1999-01-27 |
2001-05-01 |
American Cyanamid Company |
Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
|
|
US6200996B1
(en)
|
1999-01-27 |
2001-03-13 |
American Cyanamid Company |
Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
|
|
BR0007784A
(pt)
|
1999-01-27 |
2002-02-05 |
American Cyanamid Co |
Composto, método para inibir mudanças patológicas mediadas pela enzima que converte o tnf-alfa (tace) em um mamìfero, composição farmacêutica, e, processo para preparar um composto
|
|
US6544984B1
(en)
|
1999-01-27 |
2003-04-08 |
American Cyanamid Company |
2,3,4,5-tetrahydro-1H-(1,4)benzodiazepine-3-hydroxamic acids
|
|
US6946473B2
(en)
|
1999-01-27 |
2005-09-20 |
Wyeth Holdings Corporation |
Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors
|
|
US6313123B1
(en)
|
1999-01-27 |
2001-11-06 |
American Cyanamid Company |
Acetylenic sulfonamide thiol tace inhibitors
|
|
GB9903598D0
(en)
*
|
1999-02-18 |
1999-04-07 |
Univ Manchester |
Connective tissue healing
|
|
GT200000203A
(es)
|
1999-12-01 |
2002-05-24 |
|
Compuestos, composiciones y metodos para estimular el crecimiento y elongacion de neuronas.
|
|
GB0011409D0
(en)
*
|
2000-05-11 |
2000-06-28 |
Smithkline Beecham Plc |
Novel compounds
|
|
MXPA01013172A
(es)
*
|
2001-02-14 |
2002-08-21 |
Warner Lambert Co |
Inhibidores sulfonamida de metaloproteinasa de matriz.
|
|
FR2821842B1
(fr)
*
|
2001-03-07 |
2003-05-09 |
Servier Lab |
Nouveaux derives d'inhibiteurs de mettalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US6770647B2
(en)
|
2001-08-17 |
2004-08-03 |
Bristol-Myers Squibb Pharma Company |
Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE)
|
|
JP2005507937A
(ja)
|
2001-11-01 |
2005-03-24 |
ワイス・ホールディングズ・コーポレイション |
マトリックスメタロプロテイナーゼおよびｔａｃｅ阻害剤としてのアレンアリールスルホンアミドヒドロキサム酸
|
|
RU2223703C2
(ru)
*
|
2002-02-13 |
2004-02-20 |
Иркутский государственный институт усовершенствования врачей |
Способ лечения передней хронической нестабильности коленного сустава
|
|
US6716853B2
(en)
|
2002-03-02 |
2004-04-06 |
Aventis Pharma Deutschland Gmbh |
Cyclic N-substituted alpha-imino carboxylic acids for selective inhibition of collogenase
|
|
DE10209299A1
(de)
*
|
2002-03-02 |
2003-09-18 |
Aventis Pharma Gmbh |
Cyclische N-substituierte alpha-Iminocarbonsäuren zur selektiven Inhibierung von Kollagenase
|
|
US7199155B2
(en)
|
2002-12-23 |
2007-04-03 |
Wyeth Holdings Corporation |
Acetylenic aryl sulfonate hydroxamic acid TACE and matrix metalloproteinase inhibitors
|
|
AU2003292724A1
(en)
*
|
2002-12-27 |
2004-07-29 |
Japan Tobacco Inc. |
Fused n-containing heterocyclic compounds and medicinal use thereof
|
|
DE10300015A1
(de)
*
|
2003-01-03 |
2004-07-15 |
Aventis Pharma Deutschland Gmbh |
Iminosäurederivate als Inhibitoren von Matrix-Metallproteinasen
|
|
DE10344936A1
(de)
*
|
2003-09-27 |
2005-04-21 |
Aventis Pharma Gmbh |
Bicyclische Iminosäurederivate als Inhibitoren von Matrix-Metalloproteinasen
|
|
US7205315B2
(en)
|
2003-09-27 |
2007-04-17 |
Sanofi-Aventis Deutschland Gmbh |
Bicyclic imino acid derivatives as inhibitors of matrix metalloproteinases
|
|
DE10351904A1
(de)
*
|
2003-11-06 |
2005-06-09 |
Aventis Pharma Deutschland Gmbh |
Verfahren zur Herstellung von cyclischen N-substituierten alpha-Iminocarbonsäure
|
|
US7244845B2
(en)
*
|
2003-11-06 |
2007-07-17 |
Sanofi-Aventis Deutschland Gmbh |
Process for preparing cyclic N-substituted alpha-imino carboxylic acids
|
|
DE102004004974A1
(de)
*
|
2004-01-31 |
2005-08-18 |
Aventis Pharma Deutschland Gmbh |
Thieno-Iminosäure-Derivate als Inhibitoren von Matrix-Metalloproteinasen
|
|
US7705017B2
(en)
*
|
2004-05-03 |
2010-04-27 |
En Vivo Pharmaceuticals, Inc. |
Compounds for treatment of neurodegenerative diseases
|
|
DE102004031620A1
(de)
*
|
2004-06-30 |
2006-02-02 |
Sanofi-Aventis Deutschland Gmbh |
4-Trifluormethoxyphenoxybenzol-4`-sulfonsäuren, Verfahren zu ihrer Herstellung und Verwendung in Arzneimitteln
|
|
DE102004031850A1
(de)
*
|
2004-06-30 |
2006-01-26 |
Sanofi-Aventis Deutschland Gmbh |
Substituirte Tetrahydroisochinoline als MMP-Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
|
|
US7601838B2
(en)
*
|
2004-12-28 |
2009-10-13 |
Council Of Scientific And Industrial Research |
2-Alkyl/aryl sulphonyl-1,2,3,4-tetrahydro-9H-pyrido (3,4-b) indole-3-carboxylic acid esters/amides useful as antithrombotic agents
|
|
DE102005002500A1
(de)
*
|
2005-01-19 |
2006-07-27 |
Sanofi-Aventis Deutschland Gmbh |
Tetrahydrofuranderivate als Inhibitoren von Matrix-Metalloproteinasen
|
|
DE102005015040A1
(de)
*
|
2005-03-31 |
2006-10-05 |
Sanofi-Aventis Deutschland Gmbh |
Substituierte Tetrahydroisochinoline als MMP-Inhibitoren, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament
|
|
SI1901729T1
(sl)
|
2005-05-13 |
2012-05-31 |
Topotarget Uk Ltd |
Farmacevtske formulacije HDAC inhibitorjev
|
|
JP2009512844A
(ja)
*
|
2005-10-20 |
2009-03-26 |
ノルディック・バイオサイエンス・ダイアグノスティクス・アクティーゼルスカブ |
アグリカンおよびそのフラグメントの検出または定量
|
|
GB0526257D0
(en)
|
2005-12-22 |
2006-02-01 |
Novartis Ag |
Organic compounds
|
|
DK2041181T3
(da)
*
|
2006-06-08 |
2011-08-29 |
Helmholtz Zentrum Muenchen |
Specifikke proteaseinhibitorer og deres anvendelse i cancerterapi
|
|
US8790714B2
(en)
|
2007-08-03 |
2014-07-29 |
Nucitec, S.A. De C.V. |
Compositions and methods for treatment and prevention of osteoarthritis
|
|
AU2008285652B2
(en)
|
2007-08-07 |
2013-09-05 |
AbbVie Deutschland GmbH & Co. KG |
Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
|
|
US8293513B2
(en)
|
2007-12-14 |
2012-10-23 |
Georgetown University |
Histone deacetylase inhibitors
|
|
CN104352492B
(zh)
*
|
2008-04-24 |
2017-12-05 |
Msd K.K.公司 |
以芳基磺酰基衍生物作为有效成分的长链脂肪酸延长酶抑制剂
|
|
MX2011000512A
(es)
*
|
2008-07-14 |
2011-02-24 |
Novartis Ag |
Inhibidores selectivos de mmp-12 y mmp-13 basados en acido hidroxamico.
|
|
FR2947268B1
(fr)
|
2009-06-30 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-sulfonamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
FR2947270B1
(fr)
|
2009-06-30 |
2011-08-26 |
Galderma Res & Dev |
Nouveaux composes benzene-sulfonamides, leur procede de synthese et leur utilisation en medecine ainsi qu'en cosmetique
|
|
US20140275108A1
(en)
|
2013-03-15 |
2014-09-18 |
Galderma Research & Development |
Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
|
|
WO2017117130A1
(en)
|
2015-12-28 |
2017-07-06 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Methods for inhibiting human immunodeficiency virus (hiv) release from infected cells
|
|
EP3199534B1
(en)
|
2016-02-01 |
2018-09-05 |
Galderma Research & Development |
Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine and cosmetics
|
|
WO2019102488A1
(en)
|
2017-11-27 |
2019-05-31 |
Council Of Scientific & Industrial Research |
Indole (sulfomyl) n-hydroxy benzamide derivatives as selective hdac inhibitors
|
|
WO2025224168A1
(en)
|
2024-04-24 |
2025-10-30 |
Idorsia Pharmaceuticals Ltd |
Aryl sulfone and sulfanone derivatives as orexin receptor modulators
|
|
CN119565781B
(zh)
*
|
2024-12-20 |
2026-01-02 |
中南大学 |
一种金属离子-含氮芳杂环配合物捕收剂及其制备方法和在钨矿浮选中的应用
|